Sylwia Wośko

503 total citations
29 papers, 420 citations indexed

About

Sylwia Wośko is a scholar working on Pharmacology, Biological Psychiatry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sylwia Wośko has authored 29 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 13 papers in Biological Psychiatry and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sylwia Wośko's work include Tryptophan and brain disorders (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Cannabis and Cannabinoid Research (8 papers). Sylwia Wośko is often cited by papers focused on Tryptophan and brain disorders (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Cannabis and Cannabinoid Research (8 papers). Sylwia Wośko collaborates with scholars based in Poland, Sweden and Spain. Sylwia Wośko's co-authors include Ewa Poleszak, Anna Serefko, Aleksandra Szopa, Piotr Właź, Andrzej Wróbel, Aleksandra Właź, Elżbieta Wyska, Katarzyna Świąder, Urszula Doboszewska and Jarosław Dudka and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Sylwia Wośko

27 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylwia Wośko Poland 14 175 152 147 87 79 29 420
Vitor Silva Pereira Brazil 9 204 1.2× 160 1.1× 143 1.0× 54 0.6× 40 0.5× 12 428
Ariandra Guerini Sartim Brazil 11 362 2.1× 219 1.4× 138 0.9× 62 0.7× 34 0.4× 15 550
Sabrina Mioranzza Brazil 14 135 0.8× 220 1.4× 87 0.6× 100 1.1× 139 1.8× 16 647
Aleksandra Właź Poland 16 218 1.2× 333 2.2× 164 1.1× 184 2.1× 82 1.0× 46 746
Marcelo Silveira da Costa Brazil 11 145 0.8× 215 1.4× 76 0.5× 97 1.1× 142 1.8× 12 565
Kelly R. Lobato Brazil 8 107 0.6× 130 0.9× 190 1.3× 94 1.1× 17 0.2× 8 528
Zengliang Jin China 14 86 0.5× 156 1.0× 130 0.9× 125 1.4× 19 0.2× 26 437
Guadalupe Garcı́a-Alcocer Mexico 11 79 0.5× 194 1.3× 66 0.4× 209 2.4× 40 0.5× 28 689
Camille M. Ribeiro Brazil 14 142 0.8× 226 1.5× 331 2.3× 126 1.4× 27 0.3× 15 625
Priscila B. Rosa Brazil 18 200 1.1× 284 1.9× 447 3.0× 192 2.2× 42 0.5× 28 819

Countries citing papers authored by Sylwia Wośko

Since Specialization
Citations

This map shows the geographic impact of Sylwia Wośko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylwia Wośko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylwia Wośko more than expected).

Fields of papers citing papers by Sylwia Wośko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylwia Wośko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylwia Wośko. The network helps show where Sylwia Wośko may publish in the future.

Co-authorship network of co-authors of Sylwia Wośko

This figure shows the co-authorship network connecting the top 25 collaborators of Sylwia Wośko. A scholar is included among the top collaborators of Sylwia Wośko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylwia Wośko. Sylwia Wośko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serefko, Anna, Aleksandra Szopa, Mariola Herbet, et al.. (2025). The Novel Imipramine–Magnesium Complex Exerts Antidepressant-like Activity in Mice Subjected to the Forced Swim Test and the Tail Suspension Test. Molecules. 30(3). 519–519. 1 indexed citations
2.
Olender, Alina, et al.. (2025). ATR-FTIR spectroscopic markers indicating drug resistance in selected Candida strains. Scientific Reports. 15(1). 18130–18130.
3.
Poleszak, Ewa, Sylwia Wośko, Bernadeta Szewczyk, et al.. (2025). Asiatic acid potentiates the activity of common antidepressant drugs in mice. Psychopharmacology. 242(12). 2725–2737.
4.
Stępnicki, Piotr, Sylwia Wośko, Agata Bartyzel, et al.. (2023). Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia. Molecules. 28(10). 4211–4211. 1 indexed citations
5.
Poleszak, Ewa, Sylwia Wośko, Elżbieta Wyska, et al.. (2020). Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice. Pharmacological Reports. 72(6). 1562–1572. 10 indexed citations
6.
Poleszak, Ewa, Sylwia Wośko, Elżbieta Wyska, et al.. (2019). Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice. Behavioural Brain Research. 378. 112297–112297. 13 indexed citations
7.
8.
Wośko, Sylwia, Anna Serefko, Aleksandra Szopa, et al.. (2018). CB1 cannabinoid receptor ligands augment the antidepressant-like activity of biometals (magnesium and zinc) in the behavioural tests. Journal of Pharmacy and Pharmacology. 70(4). 566–575. 8 indexed citations
9.
Szopa, Aleksandra, Ewa Poleszak, Elżbieta Wyska, et al.. (2018). DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(12). 1361–1371. 20 indexed citations
10.
Poleszak, Ewa, Aleksandra Szopa, Elżbieta Wyska, et al.. (2018). Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A2A Receptor Antagonist. Neurotoxicity Research. 35(2). 344–352. 43 indexed citations
11.
Poleszak, Ewa, et al.. (2018). Cannabinoids in depressive disorders. Life Sciences. 213. 18–24. 39 indexed citations
12.
Herbet, Mariola, Aleksandra Szopa, Sylwia Wośko, et al.. (2016). The Positive Synergism of CPT and MK-801 in Behavioral Tests and in Reduction of Environmental Stress and Redox Signaling Changes in Mice Cerebral Cortex. CNS & Neurological Disorders - Drug Targets. 16(7). 837–845. 4 indexed citations
13.
Poleszak, Ewa, Aleksandra Szopa, Elżbieta Wyska, et al.. (2015). Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice. Pharmacological Reports. 68(1). 56–61. 36 indexed citations
14.
Poleszak, Ewa, Aleksandra Szopa, Elżbieta Wyska, et al.. (2015). The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice. Life Sciences. 136. 13–18. 17 indexed citations
15.
Szopa, Aleksandra, Ewa Poleszak, Elżbieta Wyska, et al.. (2015). Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(2). 211–221. 52 indexed citations
16.
Serefko, Anna, Aleksandra Szopa, Aleksandra Właź, et al.. (2015). Synergistic antidepressant-like effect of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice. Journal of Neural Transmission. 123(4). 463–472. 14 indexed citations
17.
Wośko, Sylwia, Anna Serefko, Katarzyna Socała, et al.. (2014). An anti-immobility effect of spermine in the forced swim test in mice. Pharmacological Reports. 66(2). 223–227. 10 indexed citations
18.
Poleszak, Ewa, Sylwia Wośko, Anna Serefko, et al.. (2013). Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 46. 29–35. 26 indexed citations
19.
Poleszak, Ewa, Anna Serefko, Aleksandra Szopa, et al.. (2013). NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in mice. Pharmacological Reports. 65(5). 1124–1131. 8 indexed citations
20.
Drozd, Mariola, et al.. (2013). Evaluation of students’ knowledge of cannabis influence on human health. Current Issues in Pharmacy and Medical Sciences. 26(2). 235–239. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vitor Silva Pereira Breakdown of academic impact, for papers by Ariandra Guerini Sartim Breakdown of academic impact, for papers by Sabrina Mioranzza Breakdown of academic impact, for papers by Aleksandra Właź Breakdown of academic impact, for papers by Marcelo Silveira da Costa Breakdown of academic impact, for papers by Kelly R. Lobato Breakdown of academic impact, for papers by Zengliang Jin Breakdown of academic impact, for papers by Guadalupe Garcı́a-Alcocer Breakdown of academic impact, for papers by Camille M. Ribeiro Breakdown of academic impact, for papers by Priscila B. Rosa
Rankless by CCL
2026